Laboratory Corporation of Ameri – Consensus Indicates Potential 17.5% Upside


Laboratory Corporation of America with ticker code (LH) have now 13 analysts in total covering the stock. The consensus rating is ‘Buy’. The target price ranges between 320 and 265 calculating the mean target price we have 303.69. Given that the stocks previous close was at 258.43 this is indicating there is a potential upside of 17.5%. The 50 day MA is 243.25 and the 200 day MA is 265.96. The company has a market cap of $22,987m. You can visit the company’s website by visiting: https://www.labcorp.com

The potential market cap would be $27,012m based on the market concensus.

You can now share this on Stocktwits, just click the logo below and add the ticker in the text to be seen.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. The company also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases, including anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women’s health, pharmacogenetics, and parentage and donor testing; and occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests. It provides online and mobile applications to enable patients to check test results; and online applications for managed care organizations. It offers end-to-end drug development, medical device, and diagnostic development solutions from early-stage research to clinical development and commercial market access. It serves managed care organizations, biopharmaceutical companies, physicians and other healthcare providers, hospitals and health systems, governmental agencies, employers, patients and consumers, contract research organizations, crop protection and chemical companies, academic institutions, and independent clinical laboratories. Laboratory Corporation of America Holdings has a collaboration agreement with Tigerlily Foundation to increase clinical trial diversity for women of color. The company was founded in 1971 and is headquartered in Burlington, North Carolina.

Leave a Comment